Trials / Sponsors / Collin Blakely
Collin Blakely
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skippin Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer | Phase 1 | 2022-08-10 |
| Recruiting | Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer Lung Cancer Metastatic, EGFR Gene Mutation | Phase 1 | 2019-11-12 |